These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20658139)

  • 21. Ischemic maculopathy following intravitreal bevacizumab for refractory diabetic macular edema.
    Goel N; Kumar V; Ghosh B
    Int Ophthalmol; 2011 Feb; 31(1):39-42. PubMed ID: 20852916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema.
    Stein JD; Newman-Casey PA; Kim DD; Nwanyanwu KH; Johnson MW; Hutton DW
    Ophthalmology; 2013 Sep; 120(9):1835-42. PubMed ID: 23642372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
    Mitchell P; Bandello F; Schmidt-Erfurth U; Lang GE; Massin P; Schlingemann RO; Sutter F; Simader C; Burian G; Gerstner O; Weichselberger A;
    Ophthalmology; 2011 Apr; 118(4):615-25. PubMed ID: 21459215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema.
    ; ; Aiello LP; Beck RW; Bressler NM; Browning DJ; Chalam KV; Davis M; Ferris FL; Glassman AR; Maturi RK; Stockdale CR; Topping TM
    Ophthalmology; 2011 Dec; 118(12):e5-14. PubMed ID: 22136692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indirect laser treatment and anti-VEGF therapy of a retinal angioma, with resolution of a large serous retinal detachment, macular exudates, and macular edema.
    Rarey K; Friberg TR
    Semin Ophthalmol; 2010; 25(1-2):21-6. PubMed ID: 20507193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study.
    Isaac DL; Abud MB; Frantz KA; Rassi AR; Avila M
    Acta Ophthalmol; 2012 Feb; 90(1):56-60. PubMed ID: 20015098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
    Elman MJ; Bressler NM; Qin H; Beck RW; Ferris FL; Friedman SM; Glassman AR; Scott IU; Stockdale CR; Sun JK;
    Ophthalmology; 2011 Apr; 118(4):609-14. PubMed ID: 21459214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor and diabetic macular edema.
    Lally DR; Shah CP; Heier JS
    Surv Ophthalmol; 2016; 61(6):759-768. PubMed ID: 27045225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal bevacizumab alone versus combined with macular photocoagulation in diabetic macular edema.
    Lee SJ; Kim ET; Moon YS
    Korean J Ophthalmol; 2011 Oct; 25(5):299-304. PubMed ID: 21976935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial.
    Brown DM; Ou WC; Wong TP; Kim RY; Croft DE; Wykoff CC;
    Ophthalmology; 2018 May; 125(5):683-690. PubMed ID: 29336896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema.
    Lang GE; Liakopoulos S; Vögeler J; Weiß C; Spital G; Gamulescu MA; Lohmann C; Wiedemann P
    Acta Ophthalmol; 2018 May; 96(3):e377-e385. PubMed ID: 29090846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.
    Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G
    Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of photocoagulation in ischemic areas to prevent recurrence of diabetic macular edema after intravitreal bevacizumab injection.
    Takamura Y; Tomomatsu T; Matsumura T; Arimura S; Gozawa M; Takihara Y; Inatani M
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4741-6. PubMed ID: 25028357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal anti-vascular endothelial growth factor in early pregnancy and the complex management of advance diabetic retinopathy and maculopathy during pregnancy.
    Sarmad A; Lip PL
    Acta Ophthalmol; 2016 Dec; 94(8):e812-e813. PubMed ID: 27167587
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravitreal anti-VEGF drugs as adjuvant therapy in diabetic retinopathy surgery.
    Montero JA; Ruiz-Moreno JM; Correa ME
    Curr Diabetes Rev; 2011 May; 7(3):176-84. PubMed ID: 21438852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): Report 1.
    Michaelides M; Fraser-Bell S; Hamilton R; Kaines A; Egan C; Bunce C; Peto T; Hykin P
    Retina; 2010 May; 30(5):781-6. PubMed ID: 20464787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Dabour SA
    Retina; 2013 Sep; 33(8):1623-9. PubMed ID: 23538584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
    Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E
    Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of triamcinolone and bevacizumab in central retinal vein occlusion.
    Ehlers JP; Fekrat S
    Can J Ophthalmol; 2011 Feb; 46(1):88-9. PubMed ID: 21283167
    [No Abstract]   [Full Text] [Related]  

  • 40. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
    Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
    Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.